Hydroxychloroquine merits a trial in early rheumatoid arthritis

May 1994
Modern Medicine;May94, Vol. 62 Issue 5, p59
Presents an abstract of the article entitled, `Hydroxychloroquine compared with placebo in rheumatoid arthritis: A randomized controlled trial,' by P. Clark, E. Casas, P. Tugwell et al as published in the periodical `Annals of Internal Medicine' dated December 1, 1993.


Related Articles

  • Second-line arthritis drugs are safe to use as long as they keep working.  // Modern Medicine;May96, Vol. 64 Issue 5, p45 

    Presents an abstract of the article `Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis,' by S. ten Wolde et al., published in `Lancet' journal on February 10, 1996.

  • Arthritis: Fixed-combination treatment prevents NSAID-induced ulcers.  // Modern Medicine;Dec96, Vol. 64 Issue 12, p23 

    Cites studies on drug-combination treatment for arthritis presented at the 1996 symposium of the European League Against Rheumatism. Safety and efficacy of a fixed combination of the nonsteroidal anti-inflammatory drug diclofenac and the prostaglandin misoprostol; Evaluation of quality of life...

  • Early minocycline is effective for rheumatoid arthritis.  // Modern Medicine;Aug97, Vol. 65 Issue 8, p56 

    Presents an abstract of `Treatment of Early Rheumatoid Arthritis with Minocycline or Placebo: Results of a Randomized, Double-Blind, Placebo-Controlled Trial,' by J.R. O'Dell, C.E. Haire, et al from `Arthritis Rheumatology' dated May 1997.

  • Rheumatoid arthritis: Status of drug therapies. Moncur, Carolee; Williams, H. James // Physical Therapy;Jun1995, Vol. 75 Issue 6, p61 

    Describes the current drug therapies used to manage rheumatoid arthritis (RA). Brief description of the pathology, pathogenesis, and features of RA; General approach to prescribing medication; Attributes of non-steroidal anti-inflammatory drugs, corticosteroids, anti-rheumatic drugs and...

  • Disease modifying drugs in rheumatoid arthritis. Wollheim, Frank A. // BMJ: British Medical Journal (International Edition);3/15/97, Vol. 314 Issue 7083, p766 

    Editorial. Examines the effectiveness of disease modifying drugs in rheumatoid arthritis. Symptomatology of rheumatoid arthritis; Support for early aggressive treatment based on results of an open randomized study of very early cases in the Netherlands; Appropriateness of early aggressive...

  • It's all in the timing. Morrow, Shelly // Arthritis Today;Sep/Oct96, Vol. 10 Issue 5, p13 

    Discusses the health benefits of timing medications among arthritics. Findings of a study on timing medications; Late afternoon as the optimal time of taking antiarthritic medication.

  • Prolonged use of second-line drugs in rheumatoid arthritis.  // American Family Physician;6/1/1996, Vol. 53 Issue 8, p2657 

    Reports on a study by S. Ten Wolde, et al, published in the `Lancet' which assessed the effect of stopping second-line drug therapy in patients with rheumatoid arthritis. Cumulative rate of disease flare of the different protocols; Continued effectiveness in the event of an initial good...

  • Arthritis: Methotrexate dosage can be scaled down for some patients.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p46 

    Presents an abstract of the report `Every-other-week methotrexate in patients with rheumatoid arthritis,' by J.M. Kremer et. al. published on the May 1995 issue of `Arthritis Rheumatology'.

  • New guidelines help providers manage rheumatoid arthritis. Klink, Barbara // Drug Topics;8/19/96, Vol. 140 Issue 16, p47 

    Informs that the American College of Rheumatology has published guidelines for the management of rheumatoid arthritis and monitoring drug therapy for condition. Nonsteroidal anti-inflammatories (NSAIDS) as first line of treatment; Disease-modifying antirheumatic drugs (DMARDs) as second line of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics